These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 15602099)

  • 1. Effectiveness of milnacipran for the treatment of chronic pain: a case series.
    Kamata M; Takahashi H; Naito S; Higuchi H
    Clin Neuropharmacol; 2004; 27(5):208-10. PubMed ID: 15602099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of milnacipran in the treatment of chronic pain syndromes.
    Kamata M; Naito S; Higuchi H; Suzuki A; Otani K
    Int J Psychiatry Clin Pract; 2010 Mar; 14(1):68-71. PubMed ID: 24917235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Milnacipran dose-effect study in patients with burning mouth syndrome.
    Kato Y; Sato T; Katagiri A; Umezaki Y; Takenoshita M; Yoshikawa T; Sato Y; Toyofuku A
    Clin Neuropharmacol; 2011; 34(4):166-9. PubMed ID: 21738023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dubious effect of milnacipran for the treatment of burning mouth syndrome.
    Sugimoto K
    Clin Neuropharmacol; 2011; 34(4):170-3. PubMed ID: 21738026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Milnacipran: in fibromyalgia.
    Chwieduk CM; McCormack PL
    Drugs; 2010; 70(1):99-108. PubMed ID: 20030428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels of milnacipran and its effectiveness for the treatment of chronic pain in the orofacial region.
    Kimura H; Yoshida K; Ito M; Tokura T; Nagashima W; Kurita K; Ozaki N
    Hum Psychopharmacol; 2012 May; 27(3):322-8. PubMed ID: 22585592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Durability of therapeutic response to milnacipran treatment for fibromyalgia. Results of a randomized, double-blind, monotherapy 6-month extension study.
    Goldenberg DL; Clauw DJ; Palmer RH; Mease P; Chen W; Gendreau RM
    Pain Med; 2010 Feb; 11(2):180-94. PubMed ID: 20002596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response rate obtained using milnacipran depending on the severity of depression in the treatment of major depressive patients.
    Sugawara Y; Higuchi H; Yoshida K; Takahashi H; Kamata M; Naito S; Sato K; Shimizu T
    Clin Neuropharmacol; 2006; 29(1):6-9. PubMed ID: 16518126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of milnacipran for the treatment of chronic pain in the orofacial region.
    Ito M; Kimura H; Yoshida K; Kimura Y; Ozaki N; Kurita K
    Clin Neuropharmacol; 2010; 33(2):79-83. PubMed ID: 20375656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term efficacy and safety of milnacipran compared to clomipramine in patients with major depression.
    Leinonen E; Lepola U; Koponen H; Mehtonen OP; Rimon R
    Acta Psychiatr Scand; 1997 Dec; 96(6):497-504. PubMed ID: 9421348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Milnacipran for the drastic improvement of refractory pain in a patient without depressive symptoms: a case report.
    Kito S; Nakajima T; Koga Y
    Eur Psychiatry; 2005 Jun; 20(4):355. PubMed ID: 16018932
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of efficacy and safety of milnacipran and fluoxetine in Korean patients with major depression.
    Lee MS; Ham BJ; Kee BS; Kim JB; Yeon BK; Oh KS; Oh BH; Lee C; Jung HY; Chee IS; Choe BM; Paik IH
    Curr Med Res Opin; 2005 Sep; 21(9):1369-75. PubMed ID: 16197655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pooled analysis of two randomized, double-blind, placebo-controlled trials of milnacipran monotherapy in the treatment of fibromyalgia.
    Geisser ME; Palmer RH; Gendreau RM; Wang Y; Clauw DJ
    Pain Pract; 2011; 11(2):120-31. PubMed ID: 20642487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 3-year, open-label, flexible-dosing study of milnacipran for the treatment of fibromyalgia.
    Arnold LM; Palmer RH; Ma Y
    Clin J Pain; 2013 Dec; 29(12):1021-8. PubMed ID: 23446068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled comparison of two different doses of milnacipran in major depressive outpatients.
    Kanemoto K; Matsubara M; Yamashita K; Tarao Y; Inada E; Sekine T
    Int Clin Psychopharmacol; 2004 Nov; 19(6):343-6. PubMed ID: 15486520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Milnacipran. A review of its use in depression.
    Spencer CM; Wilde MI
    Drugs; 1998 Sep; 56(3):405-27. PubMed ID: 9777315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia.
    Vitton O; Gendreau M; Gendreau J; Kranzler J; Rao SG
    Hum Psychopharmacol; 2004 Oct; 19 Suppl 1():S27-35. PubMed ID: 15378666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuing efficacy of milnacipran following long-term treatment in fibromyalgia: a randomized trial.
    Clauw DJ; Mease PJ; Palmer RH; Trugman JM; Wang Y
    Arthritis Res Ther; 2013 Aug; 15(4):R88. PubMed ID: 23953493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Milnacipran in the treatment of bulimia nervosa: a report of 16 cases.
    El-Giamal N; de Zwaan M; Bailer U; Strnad A; Schüssler P; Kasper S
    Eur Neuropsychopharmacol; 2003 Mar; 13(2):73-9. PubMed ID: 12650949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships among pain, depressed mood, and global status in fibromyalgia patients: post hoc analyses of a randomized, placebo-controlled trial of milnacipran.
    Arnold LM; Palmer RH; Gendreau RM; Chen W
    Psychosomatics; 2012; 53(4):371-9. PubMed ID: 22677218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.